Actively Recruiting
Short Integrative And Neurocognitive Therapy For Young Adults With Borderline Personality Disorder
Led by Centre Hospitalier Universitaire de Nīmes · Updated on 2025-11-24
74
Participants Needed
1
Research Sites
146 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Borderline personality disorder (BPD) is a severe, high-suicidal psychiatric disorder associated with impulsive, endangering behaviors. Young patients between 16 and 25 years old do not respond to traditional psychotherapies, which are often long and not adapted to their neurocognitive alterations linked to early trauma. The study authors hypothesize the SINTYA therapy program (one group session and one individual session weekly for 10 weeks) would reduce the level of impulsivity and clinical symptomatology (severity of the BPD; emotional regulation difficulties; dissociative symptoms; aggressiveness; ruminations; the number of self-destructive behaviors and suicidal acts; impulsive behaviors; level of suicide risk and hopelessness; the number of psychiatric hospitalizations and emergency visits for psychiatric reasons; and finally improving psychosocial functioning).
CONDITIONS
Official Title
Short Integrative And Neurocognitive Therapy For Young Adults With Borderline Personality Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Borderline Personality Disorder according to DSM-5 criteria and BPQ-80 scale
- High severity level of BPD with a ZAN-BPD score of 18 or higher out of 36
- Ability to understand, write, and read French
- Able to understand the study purpose and agree to participate in evaluations
- Signed informed consent
- For minors, parental consent signed by at least one holder of parental authority
You will not qualify if you...
- Refusal to participate in the study
- Presence of neurological disease or organic brain injury affecting cognitive performance
- Intelligence quotient below 70
- Lifetime diagnosis of schizoaffective disorder or schizophrenia
- Previous or current participation in specific psychotherapy for BPD
- Being legally deprived of liberty or protected by law
- Participation in another psychotherapy study during this study
- Participation in a drug RIPH1 study or REC study during this study
- Currently excluded from another research protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Nîmes
Nîmes, France
Actively Recruiting
Research Team
C
Clémentine Estric
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here